Psychiatric and cognitive adverse events of eslicarbazepine acetate (ESL) monotherapy on adults with focal seizures: Results from a randomized, double-blind, active-controlled study and a 2-year open-label extension study

被引：0
作者：
Dupont, S. [1 ,2 ,3 ]
Fonseca, M. M. [4 ]
Fernandez, G. Castilla [4 ]
Ikedo, F. [4 ]
Pereira, A. [4 ]
Moreira, J. [4 ]
Gama, H. [4 ]
机构：
[1] UMPC, Hop Pitie Salpetriere, AP HP, Epilepsy Unit,CNRS,ICM,UMR 7225,UMRS 975,Inserm, Paris, France
[2] UMPC, Hop Pitie Salpetriere, AP HP, Rehabil Unit,CNRS,ICM,UMR 7225,UMRS 975,Inserm, Paris, France
[3] Univ Paris Sorbonne, Paris, France
[4] BIAL Portela Ca SA, Maia, Portugal
来源：
EPILEPSIA | 2022年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
701
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
[31]   LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE (ESL): RESULTS OF A ONE-YEAR OPEN-LABEL EXTENSION OF STUDY BIA-2093-302 [J].
Gabbai, A. A. ;
Ben-Menachem, Elinor ;
Maia, Joana ;
Almeida, L. ;
Soares-da-Silva, P. .
EPILEPSIA, 2008, 49 :432-433
[32]   LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE (ESL): RESULTS OF A ONE-YEAR OPEN-LABEL EXTENSION TO STUDY BIA-2093-301 [J].
Halasz, P. ;
Elger, C. ;
Guekht, A. ;
Maia, Joana ;
Almeida, L. ;
Soares-da-Silva, P. .
EPILEPSIA, 2008, 49 :435-436
[33]   Long-Term Treatment of Partial Epilepsy with Eslicarbazepine Acetate (ESL): Results of a One-Year Open-Label Extension to Study BIA-2093-301 [J].
Versavel, Mark ;
Halasz, Peter ;
Elger, Christian ;
Guekht, Alla Borisovna ;
Maia, Joana ;
Almeida, Luis ;
Soares-da-Silva, Patricio .
NEUROLOGY, 2009, 72 (11) :A351-A351
[34]   Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study [J].
Liu, Kun ;
Wang, Hanying ;
He, Wei ;
Ye, Jian ;
Song, Yanping ;
Wang, Yusheng ;
Liu, Xiaoling ;
Wu, Zhifeng ;
Chen, Shaojun ;
Fan, Ke ;
Liu, Yuling ;
Zhang, Feng ;
Li, Zhiqing ;
Liu, Lin ;
Zhang, Junjun ;
Zhang, Xuedong ;
Ye, Junjie ;
Liang, Xiaoling ;
Li, Xiaoxin ;
Ke, Xiao ;
Wu, Quan ;
Li, Jie ;
Tao, Shanshan ;
Wang, Xinguo ;
Rosenfeld, Philip ;
Heier, Jeffrey S. ;
Kaiser, Peter ;
Xu, Xun .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (10) :1436-1443
[35]   Opicapone and non-motor symptoms in Parkinson's disease: Results from a double-blind, randomized, placebo-controlled study and open-label extension [J].
Oliveira, C. ;
Lees, A. ;
Ferreira, J. ;
Lopes, N. ;
Costa, R. ;
Pinto, R. ;
Nunes, T. ;
Rocha, J. F. ;
Soares-da-Silva, P. .
MOVEMENT DISORDERS, 2015, 30 :S173-S173
[36]   Is Quality of Life Related to Cognitive Performance or Negative Symptoms in Patients with Schizophrenia? Results from a Double-blind, Active-controlled, Lurasidone Extension Study [J].
Harvey, Philip D. ;
Loebel, Antony ;
Cucchiaro, Josephine ;
Phillips, Debra ;
Siu, Cynthia .
NEUROPSYCHOPHARMACOLOGY, 2013, 38 :S515-S515
[37]   Long-Term Exposure Of Eslicarbazepine Acetate In Asian Children With Refractory Focal Onset Seizure: Safety Results From Multicenter Phase-III, Randomized, Double-Blind Placebo Controlled And Open Label Study [J].
Gama, H. ;
Moreira, J. ;
Savic, N. ;
Magalhaes, L. ;
Ikedo, F. .
EPILEPSIA, 2019, 60 :196-196
[38]   Is Metabolic Syndrome Related to Cognitive Performance in Patients With Schizophrenia? Results From a Double-Blind, Active-Controlled, Lurasidone Study [J].
Hagi, Katsuhiko ;
Nosaka, Tadashi ;
Pikalov, Andrei .
BIOLOGICAL PSYCHIATRY, 2020, 87 (09) :S300-S301
[39]   EFFICACY OF LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY [J].
Delbello, Melissa P. ;
Goldman, Robert S. ;
Tocco, Michael ;
Pikalov, Andrei A. ;
Loebel, Antony .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10) :S231-S231
[40]   IS METABOLIC SYNDROME RELATED TO COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA? RESULTS FROM A DOUBLE-BLIND, ACTIVE-CONTROLLED, LURASIDONE STUDY [J].
Hagi, Katsuhiko ;
Nosaka, Tadashi ;
Pikalov, Andrei .
SCHIZOPHRENIA BULLETIN, 2020, 46 :S152-S152
12345